ArticleAmerican journal of translational research2019

BEZ235 increases sorafenib inhibition of hepatocellular carcinoma cells by suppressing the PI3K/AKT/mTOR pathway.

Amin Li et al.PubMed ↗Full text ↗

No numbers read from the abstract.